Evaluation of injectable robenacoxib for the treatment of post-operative pain in cats: results of a randomized, masked, placebo-controlled clinical trial

Table 5 Adverse events reported during and at post-study follow up

Adverse event	Robenacoxib (n = 174)^a		Placebo (n = 175)
Adverse event	N	% of total	N	% of total
Incision site infection, dehiscence	9	5.2	0	0
Increased incision site bleeding	6	3.4	4	2.3
Vomiting	5	2.9	0	0
Decreased appetite	4	2.3	3	1.7
Lethargy (after day of surgery)	4	2.3	2	1.1
Urinary tract infection	2	1.1	0	0
Coughing	1	0.6	0	0
Fever	1	0.6	0	0
Semiconscious^b	1	0.6	0	0
Soft stool or diarrhea	0	0	2	1.1

Cats may have experienced more than one type or occurrences of an event
^aNot including one cat treated with robenacoxib which suffered cardiopulmonary failure after a pneumothorax was caused by failure of the non-rebreathing equipment shortly after intubation
^bSemiconscious cat full recovered

ISSN: 1746-6148